These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38749300)

  • 1. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle.
    Lin WP; Li H; Sun ZJ
    EBioMedicine; 2024 Jun; 104():105154. PubMed ID: 38749300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
    Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
    Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell exhaustion in human cancers.
    Kang K; Lin X; Chen P; Liu H; Liu F; Xiong W; Li G; Yi M; Li X; Wang H; Xiang B
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189162. PubMed ID: 39089484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A
    Zhang D; Jiang D; Jiang L; Ma J; Wang X; Xu X; Chen Z; Jiang M; Ye W; Wang J; Meng W; Qiu W; Hou Y; Huang J; Jiao Y; Liu Y; Liu Z
    Br J Cancer; 2024 Jul; 131(1):184-195. PubMed ID: 38762674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of T-cell exhaustion: Mechanisms and synergistic approaches.
    Hu Y; Zhang Y; Shi F; Yang R; Yan J; Han T; Guan L
    Int Immunopharmacol; 2024 Sep; 138():112571. PubMed ID: 38941674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy.
    Bao X; Lin X; Xie M; Yao J; Song J; Ma X; Zhang X; Zhang Y; Liu Y; Han W; Liang Y; Hu H; Xu L; Xue X
    Front Immunol; 2024; 15():1413067. PubMed ID: 39026670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients.
    Niu L; Chen T; Yang A; Yan X; Jin F; Zheng A; Song X
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189125. PubMed ID: 38851437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.
    Langouo Fontsa M; Padonou F; Willard-Gallo K
    Expert Rev Clin Immunol; 2024 Aug; 20(8):839-847. PubMed ID: 39007892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.
    Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z
    Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
    Johansson-Percival A; Ganss R
    Front Immunol; 2021; 12():674375. PubMed ID: 34122434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano-Delivery Systems for Enhanced Immunotherapy.
    Huang X; Zhang W
    Small Methods; 2024 Aug; 8(8):e2301326. PubMed ID: 38040834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures and their therapeutic implications in cancer.
    Chen X; Wu P; Liu Z; Li T; Wu J; Zeng Z; Guo W; Xiong W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1579-1592. PubMed ID: 39133439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8
    Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D
    Front Immunol; 2024; 15():1476904. PubMed ID: 39372416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial dynamics of CD39
    Tanoue K; Ohmura H; Uehara K; Ito M; Yamaguchi K; Tsuchihashi K; Shinohara Y; Lu P; Tamura S; Shimokawa H; Isobe T; Ariyama H; Shibata Y; Tanaka R; Kusaba H; Esaki T; Mitsugi K; Kiyozawa D; Iwasaki T; Yamamoto H; Oda Y; Akashi K; Baba E
    Nat Commun; 2024 Oct; 15(1):9033. PubMed ID: 39426955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade.
    Tian W; Qin G; Jia M; Li W; Cai W; Wang H; Zhao Y; Bao X; Wei W; Zhang Y; Shao Q
    Front Immunol; 2023; 14():1198551. PubMed ID: 37398674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].
    Fridman WH; Petitprez F; Sautes-Fridman C
    Bull Cancer; 2020 Apr; 107(4):403-404. PubMed ID: 32284150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.